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Background: Ankle-brachial pressure index (ABI) is an independent pre-
dictor of the extent of coronary atherosclerosis and cardiovascular events. To
date ABI measurement is not part of the routine examination in patient
admitted for coronary angiography. Our objective was to establish ABI measu-
rement as a routine procedure in our interventional cardiology unit to amelio-
rate the assessment of coronary risk level for patients admitted for scheduled
coronary angiography. 
Method: ABI measurement was performed on admission using a doppler ultra-
sonic instrument. Patients with past medical history of peripheral arteriopathy were
excluded. Cardiovascular risk factors and clinical findings were collected. Correla-
tions and multivariate analysis were performed on R software. 
Results: In the pilot study, 40 consecutive patients were included between
February and April 2009. 79% were males and the mean age was 66+/-12 years.
ABI < 0.9 was found in 6 patients. Significant multivessel disease was found in
10 patients: 6 with ABI<0.9 and 4 with ABI≥0.9. Patients with ABI<0.9 were
significantly older 75+/-11 vs 64+/-12 (p=0.04) and had a trend for lower glo-
merular filtration rate MDRD=61+/-21 vs 77+/-20 mL/min/1.73m_ (p=0.08). 5-
years probability of cardiovascular death was 12+/-7.4% in patients with
ABI<0.9 vs 7.2+/-7.6 in patients with ABI≥0.9 (p=ns). Multivariate analysis
showed that ABI remains a significant predictor of multivessel disease after
adjustment on other risk factors. Low ABI was significantly correlated with 5
years probability of cardiovascular death (spearman = -0.36, P=0.03). 
Conclusion: ABI was an independent predictor of coronary multivessel
disease and 5 years probability of cardiovascular death. Routine ABI measu-
rement in patients with known or suspected coronary artery disease provides
additional information regarding patient’s risk and may be taken into account
to establish optimal care strategy.
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Background: Dual antiplatelet therapy with aspirin (Asa) and clopido-
grel (Clopi) is the cornerstone of treatment for patients (pts) after angioplasty
(PCI). The state of dual antiplatelet responsiveness is not well known espe-
cially in elderly pts.
Objectives: The aim of this monocentric prospective observational study is
to evaluate Asa and Clopi activity after PCI in elderly pts and to asses the evo-
lution of this responsiveness at 5 weeks.
Methods: We enrolled 81 elderly pts (≥75 years) from Jan to Dec 2008
on Asa (75 mg/day ≥ 7 days) and Clopi (after loading dose 300 mg before PCI
and 150mg /day for 4 weeks fellowed by 75 mg/ day for 1 year). We used the
VerifyNow Asa assay and the VerifyNow Clopi P2Y12 assay (Accumetrics
Inc, USA) to determinate respectively Asa and Clopi responsiveness in-hos-
pital at 11.30 am (T1) and during a medical consultation at 5 weeks (T2).
Results: Asa non responders were noted in 10% and in 14% pts at respec-
tively T1 and T2, Clopi non responders in 37% and in 70% pts at respectively
T1 and T2. Significant changes were observed in Clopi response from res-
ponder to non responder (p < 0.001); similarly changes were noticed but in
both ways for Asa response from T1 to T2 (p=0.005). Mutivariate analysis
revelead plasma-HDL-cholesterol (OR [0.81]; 95% CI[0.67 to 0.98];p=0.031;
for a raising of 0.1 mmol/L) and hematocrit level (OR [0.85]; 95% CI [0.75 to
0.96]; p=0.008 for an increasing of 1%) to be independent predictors of Clopi
non responsiveness at T1; in the same way diabetes (OR [0.30]; 95% CI [0.10
to 0.95]; p=0.041; for non diabetes vs diabetes) and hematocrit level (OR
[0.8]; 95% CI [0.77 to 1.00]; p=0.045 for an increasing of 1%) are independtly
associated with Clopi non responsiveness at T2.
Conclusions: In elderly, after PCI, there are changes in dual antiplatelet
responsiveness between tests in-hospital and at 5 weeks marked for Clopi acti-
vity. Low hematocrit remains an independent predictor of Clopi non responsi-
veness.
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Predictive factors of ST-segment resolution after primary angioplasty
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In the setting of acute myocardial infarction (AMI), early resolution of ST-
segment elevation was a useful predictor of final infarct size, left ventricular
function and clinical outcome.
Aim: to determine the predictive factors of ST-segment resolution imme-
diately following primary coronary angioplasty for AMI.
Methods: primary angioplasty was performed in 270 consecutive patients
with first AMI, they were divided into 2 groups according to whether ST-seg-
ment resolution occurred 1 hour after the procedure. ST-segment resolution ≥
70% was considered as ‘complete’ ST-segment resolution, whereas ST-seg-
ment resolution < 70% was considered as ‘incomplete’ ST-segment resolution.
Results: of the 270 patients, 156 (57.8%) had complete ST-segment reso-
lution. Patients with pre-infarction angina had a greater degree of ST-segment
resolution than those without angina (71 ±21 % vs. 49± 43%, p<0.02).
On multivariate analysis, the absence of pre-infarction angina (OR=2.7; CI
1.7-3.4,p=0.03) as well as the admission after H4 (OR=3.5; CI 1.58-8.06,
p=0.002), patient age ≥ 70 year(OR= 5.6; CI 2.23-14.4,p<0.001) and initial
TIMI flow grade 0/1 (OR=13.6; CI 4.5-21.2, p<0.001) were major indepen-
dent predictors of poor ST-segment resolution; whereas sex, coronary risk fac-
tors, killip class on admission, multivessel disease and extent of collaterals
were not significant.
There was a significant difference in survival free of major adverse cardio-
vascular events, at multivariate analysis =, incomplete ST-segment resolution
was an independent factor of 1-year mortality (p=0.016).
Conclusions: Rapid ST-segment resolution was associated with a better
clinical outcome and prognosis after successful primary PTCA. Pre-infarction
angina, age < 70 years, TIMI flow 2/3 and ischemia time < 4 hours were asso-
ciated with a greater degree of ST-segment resolution after primary angio-
plasty.
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Rationale and aim: Elevated C-reactive protein level is a risk marker in
patients with acute coronary syndromes (ACS), but current risk score systems
do not consider this factor. We studied the incremental predictive value of
adding CRP to the GRACE risk score.
